Douglas DiRuggiero, DMSc, PA-C, Skin Cancer and Cosmetic Dermatology Center

Keri Holyoak, PA-C, MPH, reacts to the FDA approval of dupilumab for atopic dermatitis and explains what makes this therapy unique compared to other treatment options.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C discuss best practices in the non-pharmacologic management of atopic dermatitis including elimination of triggers, bathing, and reducing infection risk.

The rationale for using systemic therapies such as methotrexate, azathioprine, phototherapy, or others to treat patients with severe, persistent atopic dermatitis.

Best practices using topical therapies to treat atopic dermatitis and managing treatment-related adverse events.

Experts in dermatology discuss the clinical presentation of atopic dermatitis, common comorbidities associated with the disease, and its impact on patient quality of life.

Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, and Douglas DiRuggiero, DMSc, PA-C, provide an overview of atopic dermatitis including prevalence, age of onset, and diagnosis.

Non-pharmacological strategies that can help patients with atopic dermatitis cope with symptoms and advice to help healthcare professionals counsel patients on proper use of these products and techniques.

Recommendations on educating primary care physicians about atopic dermatitis and the importance of early referral to dermatologists.

The differences in early skin immune changes in pediatric atopic dermatitis (AD) versus long-standing adult AD and variations in the condition’s presentation among patients of color.

Opening a discussion regarding best practices in managing patients with atopic dermatitis, Douglas DiRuggiero, DMSc, PA-C, describes its relationship to eczema and explains at what age it commonly presents in patients.